Teva Sues Reckitt Over UK Generic-Drug Delay Tactics

Law360, New York (June 28, 2013, 7:47 PM EDT) -- Teva UK Ltd. has accused Reckitt Benckiser Group PLC of trying to thwart generic competition for its heartburn treatment by pulling one version of the drug from the country's official prescription list once its patent protection expired, the U.K.'s competition court said Friday.

Teva has sued for damages from Reckitt in the wake of a decision from the country's antitrust watchdog holding that the British pharmaceutical company had abused its dominance by withdrawing Gaviscon heartburn medication from the National Health Service's prescription list in favor of...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.